Quanterix Gets National Institutes of Well being RADx Agreement to Progress Antigen Exam for SARS-CoV-2 (COVID-19)
$18.2 million in Period 2 funding will help the progress and scale-up of COVID-19 antigen check based on Simoa® technological know-how Quanterix Company (NASDAQ: QTRX), a enterprise digitizing biomarker evaluation…